Evidence map›Paper›PMID 42143612›Full record

ArticleThe British journal of radiology2026

A multi-centre real-world evaluation of AI-assisted organ at risk contouring on radiotherapy treatment planning workflows.

Catriona Inverarity, Benjamin Caswell-Midwinter, Babak Jamshidi, Man Ting Kwong, Chloe Black, Akashdeep Singh Chauhan, Fowzia Ibrahim, Ami Mehta, Kim Fell, Mark Gooding and 8 more

Abstract readMulticenter Study
In one paragraph

Article in The British journal of radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Catriona InverarityKing's Technology Evaluation Centre, London Institute for Healthcare Engineering, King's College London, London SE1 7AR, United Kingdom.ORCID 0000-0001-5107-7065
Benjamin Caswell-MidwinterKing's Technology Evaluation Centre, London Institute for Healthcare Engineering, King's College London, London SE1 7AR, United Kingdom.ORCID 0000-0002-3386-3860
Babak JamshidiKing's Technology Evaluation Centre, London Institute for Healthcare Engineering, King's College London, London SE1 7AR, United Kingdom.ORCID 0000-0002-5995-367X
Man Ting KwongKing's Technology Evaluation Centre, London Institute for Healthcare Engineering, King's College London, London SE1 7AR, United Kingdom.ORCID 0000-0002-1965-5053
Chloe BlackKing's Technology Evaluation Centre, London Institute for Healthcare Engineering, King's College London, London SE1 7AR, United Kingdom.ORCID 0000-0003-2946-0943
Akashdeep Singh ChauhanKing's Technology Evaluation Centre, London Institute for Healthcare Engineering, King's College London, London SE1 7AR, United Kingdom.ORCID 0000-0001-6791-2221
Fowzia IbrahimCentre for Rheumatic Diseases, Department of Inflammation Biology, School of Immunology and Microbial Sciences, Faculty of Life Sciences and Medicine, King's College London, London SE5 9RJ, United Kingdom.ORCID 0000-0002-7069-8024
Ami MehtaCancer National Programme of Care, Specialised Commissioning, NHS England, London, United Kingdom.
Kim FellSpecialised Commissioning Team, NHS England, London SE1 8UG, United Kingdom.
Mark GoodingInpictura Ltd, Abingdon OX14 3PX, United Kingdom.ORCID 0000-0002-1177-5608
Chris WalkerRadiotherapy Physics, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne NE7 7DN, United Kingdom.
Keith LangmackRadiotherapy Physics, Nottingham University Hospitals NHS Trust, Nottingham NG5 1PB, United Kingdom.ORCID 0009-0009-6979-4084
Alison GriffithsResearch Economics and Consultancy in Healthcare Ltd., Solihull, United Kingdom.
Salma AyisSchool of Life Course and Population Sciences, King's College London, London SE1 1UL, United Kingdom.ORCID 0000-0002-0449-869X
Juan I BaezaDepartment of Public Services Management & Organisation, King's Business School, King's College London, London WC2B 4BG, United Kingdom.ORCID 0000-0003-2032-4507
Jon HindmarshDepartment of Public Services Management & Organisation, King's Business School, King's College London, London WC2B 4BG, United Kingdom.ORCID 0000-0002-8162-1997
Angie A KehagiaKing's Technology Evaluation Centre, London Institute for Healthcare Engineering, King's College London, London SE1 7AR, United Kingdom.ORCID 0000-0002-5142-7456
Anna BarnesKing's Technology Evaluation Centre, London Institute for Healthcare Engineering, King's College London, London SE1 7AR, United Kingdom.ORCID 0000-0002-6902-214X

Funding

Accelerated Access CollaborativeArtificial Intelligence in Health and CareDepartment of Health and Social CareNational Institute for Health and Care ResearchNHS
6 · The paper itself

Abstract

objectivesThis multicentre real-world evaluation, commissioned by NHS England, evaluated the impact of AI-assisted contouring of organs at risk on contour acceptability, workflows, and staffing.

methodsData from 626 patients were collected from eight NHS radiotherapy departments. Time metrics from the date of planning CT scan to the start of first treatment were compared between manual and AI-enabled pathways. Acceptability scores for AI-generated contours were also collected.

resultsAI-assisted contouring increased potential efficiency in treatment planning compared to manual methods, reducing time for contouring and redistributing workload across different staff types. 100% of manual contour reviews involved clinical oncologists compared to 38% reviewing AI-generated contours. However, workflow design meant that time saving was not observed across the whole treatment planning pathway. AI contours were generally well accepted, with 15.9% requiring no edits and 64.4% only minor edits. This varied by anatomy, with breast having the best acceptability and prostate and head and neck contours requiring more editing.

conclusionsAI contouring tools have the potential to enhance efficiency in radiotherapy treatment planning, creating operational flexibility. Pathway review and revision could unlock further benefits, for example, involving different staff types to address local bottlenecks. Workflow, capacity, and staffing review pre- and post-implementation could increase efficiency gains with AI-assisted contouring. ADVANCES IN KNOWLEDGE: This study evaluated AI contouring tools in complex, real-world systems which differ between departments for generalizable conclusions. It describes the changes in time across the whole treatment planning pathway and the system-level impact of using AI tools to help inform holistic planning.

Indexed as

Artificial IntelligenceOrgans at RiskRadiotherapy Planning, Computer-AssistedWorkflowEnglandFemaleHumansMaleTomography, X-Ray ComputedacceptabilityAI-assisted contouringauto-contouringhealth technology assessmentorgans at riskradiotherapy treatment planningreal-world evaluationstaff involvementtime savingsworkflow optimization

Identifiers

PMID42143612
PMCPMC13389072

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.